annual FCF:
-$356.19M-$173.26M(-94.72%)Summary
- As of today (July 4, 2025), BEAM annual free cash flow is -$356.19 million, with the most recent change of -$173.26 million (-94.72%) on December 31, 2024.
- During the last 3 years, BEAM annual FCF has fallen by -$243.11 million (-214.99%).
- BEAM annual FCF is now -1247.99% below its all-time high of -$26.42 million, reached on December 31, 2022.
Performance
BEAM Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$106.95M-$27.61M(-34.81%)Summary
- As of today (July 4, 2025), BEAM quarterly free cash flow is -$106.95 million, with the most recent change of -$27.61 million (-34.81%) on March 31, 2025.
- Over the past year, BEAM quarterly FCF has dropped by -$4.76 million (-4.66%).
- BEAM quarterly FCF is now -150.63% below its all-time high of $211.23 million, reached on March 31, 2022.
Performance
BEAM quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$360.96M-$4.76M(-1.34%)Summary
- As of today (July 4, 2025), BEAM TTM free cash flow is -$360.96 million, with the most recent change of -$4.76 million (-1.34%) on March 31, 2025.
- Over the past year, BEAM TTM FCF has dropped by -$191.68 million (-113.23%).
- BEAM TTM FCF is now -343.55% below its all-time high of $148.21 million, reached on March 31, 2022.
Performance
BEAM TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
BEAM Free cash flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -94.7% | -4.7% | -113.2% |
3 y3 years | -215.0% | -150.6% | -343.6% |
5 y5 years | -321.4% | -251.4% | -283.9% |
BEAM Free cash flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -1248.0% | at low | -181.3% | +7.7% | -393.5% | +7.9% |
5 y | 5-year | -1248.0% | at low | -150.6% | +7.7% | -343.6% | +7.9% |
alltime | all time | -1248.0% | at low | -150.6% | +7.7% | -343.6% | +7.9% |
BEAM Free cash flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$106.95M(+34.8%) | -$360.96M(+1.3%) |
Dec 2024 | -$356.19M(+94.7%) | -$79.33M(-11.6%) | -$356.19M(+145.0%) |
Sep 2024 | - | -$89.70M(+5.6%) | -$145.37M(-5.2%) |
Jun 2024 | - | -$84.97M(-16.8%) | -$153.40M(-9.4%) |
Mar 2024 | - | -$102.19M(-177.7%) | -$169.28M(-7.5%) |
Dec 2023 | -$182.93M(+592.3%) | $131.48M(-234.5%) | -$182.93M(-53.3%) |
Sep 2023 | - | -$97.73M(-3.1%) | -$391.86M(+3.0%) |
Jun 2023 | - | -$100.85M(-12.9%) | -$380.41M(+7.6%) |
Mar 2023 | - | -$115.83M(+49.6%) | -$353.49M(+1237.7%) |
Dec 2022 | -$26.42M(-76.6%) | -$77.45M(-10.2%) | -$26.42M(-166.9%) |
Sep 2022 | - | -$86.28M(+16.7%) | $39.49M(-67.9%) |
Jun 2022 | - | -$73.92M(-135.0%) | $123.00M(-17.0%) |
Mar 2022 | - | $211.23M(-1930.6%) | $148.21M(-231.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$113.08M(+0.9%) | -$11.54M(+316.1%) | -$113.08M(-15.6%) |
Sep 2021 | - | -$2.77M(-94.3%) | -$133.96M(-13.7%) |
Jun 2021 | - | -$48.71M(-2.7%) | -$155.22M(+17.8%) |
Mar 2021 | - | -$50.06M(+54.4%) | -$131.72M(+17.5%) |
Dec 2020 | -$112.10M(+32.6%) | -$32.42M(+34.9%) | -$112.10M(+12.5%) |
Sep 2020 | - | -$24.03M(-4.7%) | -$99.64M(+6.0%) |
Jun 2020 | - | -$25.20M(-17.2%) | -$94.01M(+8.4%) |
Mar 2020 | - | -$30.44M(+52.5%) | -$86.75M(+2.6%) |
Dec 2019 | -$84.52M(+152.9%) | -$19.96M(+8.4%) | -$84.52M(+30.9%) |
Sep 2019 | - | -$18.41M(+2.6%) | -$64.56M(+39.9%) |
Jun 2019 | - | -$17.94M(-36.4%) | -$46.15M(+63.6%) |
Mar 2019 | - | -$28.21M | -$28.21M |
Dec 2018 | -$33.42M | - | - |
FAQ
- What is Beam Therapeutics annual free cash flow?
- What is the all time high annual FCF for Beam Therapeutics?
- What is Beam Therapeutics annual FCF year-on-year change?
- What is Beam Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Beam Therapeutics?
- What is Beam Therapeutics quarterly FCF year-on-year change?
- What is Beam Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Beam Therapeutics?
- What is Beam Therapeutics TTM FCF year-on-year change?
What is Beam Therapeutics annual free cash flow?
The current annual FCF of BEAM is -$356.19M
What is the all time high annual FCF for Beam Therapeutics?
Beam Therapeutics all-time high annual free cash flow is -$26.42M
What is Beam Therapeutics annual FCF year-on-year change?
Over the past year, BEAM annual free cash flow has changed by -$173.26M (-94.72%)
What is Beam Therapeutics quarterly free cash flow?
The current quarterly FCF of BEAM is -$106.95M
What is the all time high quarterly FCF for Beam Therapeutics?
Beam Therapeutics all-time high quarterly free cash flow is $211.23M
What is Beam Therapeutics quarterly FCF year-on-year change?
Over the past year, BEAM quarterly free cash flow has changed by -$4.76M (-4.66%)
What is Beam Therapeutics TTM free cash flow?
The current TTM FCF of BEAM is -$360.96M
What is the all time high TTM FCF for Beam Therapeutics?
Beam Therapeutics all-time high TTM free cash flow is $148.21M
What is Beam Therapeutics TTM FCF year-on-year change?
Over the past year, BEAM TTM free cash flow has changed by -$191.68M (-113.23%)